Back to
Jacobs Levy Equity Management, Inc.
RNAC
5 quarters
Position history for
Jacobs Levy Equity Management, Inc.'s holdings in Cartesian Therapeutics, Inc.
No. Jacobs Levy Equity Management exited its RNAC (Cartesian Therapeutics) position in Q2 2026. Its Q1 2026 13F listed 101,534 shares worth $624,434. Jacobs Levy Equity Management first reported RNAC in Q2 2025 and held it in 4 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$429,284
Total Shares Change
-41,317
Quarter-by-Quarter History
Other major holders of RNAC: FMR LLC, Squarepoint Ops LLC